EP3371165
BTK hemill til notkunar við að meðhöndla krabbamein
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.11.2016EP published:
26.1.2022EP application number:
16804956.7
EP translation filed:
1.4.2022Grant published:
15.5.2022EPO information:
European Patent Register
Max expiry date:
3.11.2036Expiry date:
3.11.2026Next due date:
30.11.2026
Title in English:
A BTK INHIBITOR FOR USE IN TREATING CANCERLanguage of the patent:
English
Timeline
Today
4.11.2016EP application
26.1.2022EP Publication
1.4.2022Translation submitted
15.5.2022Registration published
3.11.2026Expires
Owner
Name:
Merck Patent GmbHAddress:
Frankfurter Strasse 250, 64293 Darmstadt, DE
Inventor
Name:
HUCK, Bayard R.Address:
61440 Oberursel, DE
Name:
GOODSTAL, Samantha M.Address:
Lexington, Massachusetts 02421, US
Name:
GIMMI-MCKIM, ClaudeAddress:
4313 Moehlin, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562250575 PDate:
4.11.2015Country:
US
Number:
201662296143 PDate:
17.2.2016Country:
US
Number:
201662341189 PDate:
25.5.2016Country:
US
Classification
Categories:
C07D 401/12, A61K 31/506, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 6.10.2022
Expires: 3.11.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 9.11.2023
Expires: 3.11.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 8.10.2024
Expires: 3.11.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 4.11.2025
Expires: 3.11.2026
Payer: Árnason Faktor ehf.